AGN,BRIEF-Allergan unlikely to pursue Biogen deal- CNBC,citing source * Allergan unlikely to pursue Biogen deal- CNBC,citing source    (Bengaluru Newsroom: +1-646-223-8780) ~REFILE-Biogen draws takeover interest from Merck, Allergan - WSJ Aug 2 Biotechnology giant Biogen Inc  has drawn takeover interest from drug companies including Merck & Co Inc and Allergan Plc, the Wall Street Journal reported, citing people familiar with the matter. ~BRIEF-Biogen has drawn takeover interest from drug companies including Merck & Co and Allergan - WSJ * Biogen has drawn takeover interest from drug companies including Merck & Co and Allergan Plc- WSJ, citing sources  Source (http://on.wsj.com/2b0s6q9)   (Bengaluru Newsroom: +1-646-223-8780) ~BRIEF-Allergan completes divestiture of global generics business to Teva Pharmaceuticals * Allergan PLC completes divestiture of Global Generics Business to Teva Pharmaceuticals ~Pfizer beats estimates, but branded drugs disappoint Pfizer Inc  reported better-than-expected quarterly results, driven by lower taxes and sales of generic medicines, but revenue from its branded patent-protected medicines brought disappointment. ~UPDATE 5-Pfizer beats estimates, but branded drugs disappoint Aug 2 Pfizer Inc reported better-than-expected quarterly results, driven by lower taxes and sales of generic medicines, but revenue from its branded patent-protected medicines brought disappointment. ~Pfizer revenue rises 11 percent Aug 2 Pfizer Inc's quarterly revenue rose about 11 percent, driven by sales of newer drugs and the acquisition of hospital products company Hospira last year. ~
GOOGL.O,BRIEF-Moody's assigns AA2 rating to Alphabet Inc's new senior unsecured notes * Moody's assigns AA2 rating to Alphabet Inc's new senior unsecured notes ~
GOOG.O,BRIEF-Moody's assigns AA2 rating to Alphabet Inc's new senior unsecured notes * Moody's assigns AA2 rating to Alphabet Inc's new senior unsecured notes ~
AAPL.O,OpenTV owner settles patent dispute with Apple NEW YORK/ZURICH Swiss digital TV security company Kudelski  on Tuesday reached a settlement with Apple Inc, ending a patent dispute in the United States and Europe and removing a threat to Apple's video streaming features in devices sold in Germany. ~OpenTV owner settles patent dispute with Apple NEW YORK/ZURICH, Aug 2 Swiss digital TV security company Kudelski on Tuesday reached a settlement with Apple Inc, ending a patent dispute in the United States and Europe and removing a threat to Apple's video streaming features in devices sold in Germany. ~UPDATE 2-Infineon misses profit forecast as smartphone chip demand stagnates * Shares 3.9 percent lower in early trade   (Adds detail, background about smartphone market, updates shares) ~BRIEF-Kudelski and Apple settle patent litigation * Under agreement, parties agreed to dismiss all pending patent litigation. Financial terms were not disclosed  Source text for Eikon:  Further company coverage:    (Gdynia Newsroom) ~
ADM,ADM eyes ethanol asset sales as weak margins hit second-quarter profit CHICAGO U.S. grain trader Archer Daniels Midland Co  is pulling back in ethanol and exploring sales of its corn dry mills that produce the biofuel, the company said Thursday after reporting a lower second-quarter profit due partly to weak ethanol results. ~UPDATE 3-ADM eyes ethanol asset sales as weak margins hit Q2 profit CHICAGO, Aug 2 U.S. grain trader Archer Daniels Midland Co is pulling back in ethanol and exploring sales of its corn dry mills that produce the biofuel, the company said Thursday after reporting a lower second-quarter profit due partly to weak ethanol results. ~BRIEF-ADM Q2 earnings per share $0.48 * ADM reports second quarter earnings of $0.48 per share, $0.41 per share on an adjusted basis ~ADM reports 26 percent fall in quarterly profit Aug 2 U.S. agricultural trader Archer Daniels Midland Co reported a 26 percent fall in quarterly profit as merchandising and handling earnings declined in its agriculture services unit. ~
BIIB.O,UPDATE 4-Biogen draws takeover interest from Merck, Allergan-WSJ Aug 2 Biotechnology company Biogen Inc  has drawn takeover interest from drug companies including Merck & Co Inc and Allergan Plc, The Wall Street Journal reported on Tuesday, citing people familiar with the matter. ~BRIEF-Allergan unlikely to pursue Biogen deal- CNBC,citing source * Allergan unlikely to pursue Biogen deal- CNBC,citing source    (Bengaluru Newsroom: +1-646-223-8780) ~UPDATE 3-Biogen draws takeover interest from Merck, Allergan -WSJ Aug 2 Biotechnology company Biogen Inc  has drawn takeover interest from drug companies including Merck & Co Inc and Allergan Plc, The Wall Street Journal reported on Tuesday, citing people familiar with the matter. ~Wall St. falls as weak auto sales spur growth jitters NEW YORK Wall Street stocks fell on Tuesday, with each of the major indexes notching their worst day in about a month as economic data and weaker-than-expected auto sales spurred concerns about growth. ~US STOCKS-Wall St falls as weak auto sales spur growth jitters * Indexes down: Dow 0.49 pct, S&P; 0.64 pct, Nasdaq 0.9 pct   (Updates to market close) ~REFILE-Biogen draws takeover interest from Merck, Allergan - WSJ Aug 2 Biotechnology giant Biogen Inc  has drawn takeover interest from drug companies including Merck & Co Inc and Allergan Plc, the Wall Street Journal reported, citing people familiar with the matter. ~
CBS,UPDATE 1-Viacom and Redstone's National Amusements held settlement talks -WSJ Aug 2 Top Viacom Inc executives recently held discussions with National Amusements Inc to settle litigation related to control of Sumner Redstone's media empire, the Wall Street Journal reported on Tuesday. ~
CVS,UPDATE 2-CVS Health's profit beats estimates on pharma business strength * Shares up 3 pct premarket   (Adds details, analyst comment, shares) ~BRIEF-CVS Health Q2 GAAP earnings per share $0.86 * Sees q3 2016 adjusted earnings per share $1.55 to $1.58 excluding items ~Drugstore chain CVS's revenue jumps on pharma business Aug 2 CVS Health Corp, the No. 2 U.S. drugstore chain by store count, reported a 17.6 percent rise in quarterly revenue, helped by strength in its pharmacy business. ~
DVN,Devon Energy posts surprising adjusted profit on cost cuts HOUSTON U.S. oil producer Devon Energy Corp  posted an unexpected adjusted quarterly profit on Tuesday and narrowed its net loss as drastic cost cuts, especially in labor and supply expenses, offset the slump in crude prices . ~UPDATE 1-Devon Energy posts surprising adjusted profit on cost cuts HOUSTON, Aug 2 U.S. oil producer Devon Energy Corp posted an unexpected adjusted quarterly profit on Tuesday and narrowed its net loss as drastic cost cuts, especially in labor and supply expenses, offset the slump in crude prices. ~Devon Energy quarterly loss shrinks due to cost cuts HOUSTON, Aug 2 U.S. oil producer Devon Energy Corp said on Tuesday its quarterly loss shrank as it slashed costs, especially labor and supply expenses, to offset low crude prices. ~
DISCA.O,BRIEF-Discovery Communications reported Q2 EPS $0.66 * Q2 revenue rose 3 percent to $1.708 billion  Source text for Eikon:  Further company coverage:    (Bengaluru Newsroom +1-646-223-8780) ~
DISCK.O,BRIEF-Discovery Communications reported Q2 EPS $0.66 * Q2 revenue rose 3 percent to $1.708 billion  Source text for Eikon:  Further company coverage:    (Bengaluru Newsroom +1-646-223-8780) ~
EA.O,UPDATE 1-EA posts unexpected profit on higher game downloads Aug 2 Video-game publisher Electronic Arts Inc , known for titles such as "FIFA" and "Star Wars Battlefront", reported an unexpected first-quarter profit, helped by higher downloads of its games. ~BRIEF-Electronic Arts Q1 GAAP shr $1.40 * Q1 non-gaap earnings per share $0.07; q1 non-gaap revenue $682 million versus. $693 million last year ~EA revenue beats estimates on higher game downloads Aug 2 Video-game publisher Electronic Arts Inc , known for titles such as "FIFA" and "Star Wars Battlefront", reported first-quarter revenue that beat analysts' estimates, helped by higher downloads of its games. ~
EMR,UPDATE 2-Emerson Electric to sell businesses for $5.2 bln * Says global economic conditions continue to hurt business   (Adds details, background; Updates share movement) ~BRIEF-Emerson Electric q3 adjusted EPS $0.80 * Q3 results "continued to reflect low growth global environment facing our businesses" ~BRIEF-Emerson agrees to sell Network Power for $4 billion * Emerson reaches agreement to sell network power for $4 billion to platinum equity ~Acquisitive Nidec snaps up another Emerson unit for $1.2 billion TOKYO Japan's Nidec Corp  said it would buy Emerson Electric Co's  motors and electric power generation unit for $1.2 billion, seeking to expand its industrial and commercial businesses as the market for consumer goods such as smartphones and laptops slows. ~BRIEF-Emerson reports Q3 earnings per share $0.74 * Q3 earnings per share view $0.84 -- Thomson Reuters I/B/E/S ~BRIEF-Emerson Electric to sell Leroy-Somer and Control Techniques Businesses to Nidec Corp for $1.2 bln * Emerson to sell Leroy-Somer and Control Techniques Businesses to Nidec Corporation ~UPDATE 2-Acquisitive Nidec snaps up another Emerson unit for $1.2 bln TOKYO, Aug 2 Japan's Nidec Corp said it would buy Emerson Electric Co's motors and electric power generation unit for $1.2 billion, seeking to expand its industrial and commercial businesses as the market for consumer goods such as smartphones and laptops slows. ~Emerson Electric to sell network power unit for $4 bln Aug 2 Emerson Electric Co, a maker of factory automation equipment, said it would sell its network power unit to investment firm Platinum Equity in a deal valued at $4 billion. ~Nidec to buy Emerson's motors and drives unit for $1.2 bln TOKYO, Aug 2 Japan's Nidec Corp said on Tuesday it would buy Emerson Electric Co's motors and drives unit for $1.2 billion, confirming a Reuters report last week. ~
FMC,UPDATE 2-Fresenius Medical's cost cuts lift earnings and shares * Parent Fresenius raises FY profit goal on infusion drugs   (Releads, adds shares, analyst comment) ~
F,U.S. consumer spending exits second quarter with strong momentum WASHINGTON U.S. consumer spending rose more than expected in June as households bought goods and services, suggesting strength that appeared to be sustained early in the third quarter with auto sales surging to an eight-month high in July. ~WRAPUP 3-U.S. consumer spending exits second quarter with strong momentum WASHINGTON, Aug 2 U.S. consumer spending rose more than expected in June as households bought goods and services, suggesting strength that appeared to be sustained early in the third quarter with auto sales surging to an eight-month high in July. ~BRIEF-Ford Motor reports July vehicle sales * July U.S. vehicle sales were 216,479, down 3 percent, with fleet up 6 percent and retail down 6 percent  Source text for Eikon:  Further company coverage: ~
GE,Fitch Publishes General Electric & GE Capital's 'AA-/F1+' Ratings; Outlook Stable (The following statement was released by the rating agency) CHICAGO, August 02 (Fitch) Fitch Ratings has published 'AA-/F1+' Long- and  Short-Term Issuer Default Ratings (IDRs) for General Electric Company (GE) and  GE Capital Global Holdings, LLC (GE Capital). Fitch has also published debt  ratings for GE and GE Capital, including those of certain GE Capital  subsidiaries. The Rating Outlook is Stable. Approximately $156 billion of GE's  consolidated debt is covered by the ratings. Fitch's rati ~
GM,WRAPUP 3-U.S. consumer spending exits second quarter with strong momentum WASHINGTON, Aug 2 U.S. consumer spending rose more than expected in June as households bought goods and services, suggesting strength that appeared to be sustained early in the third quarter with auto sales surging to an eight-month high in July. ~
GT.O,UPDATE 1-Activist hedge fund Marcato gains 10.4 pct in July BOSTON, Aug 2 Marcato International, an activist hedge fund that mainly bets on U.S. equities, returned 10.4 percent in July, handily beating the broader stock market index's gain, when the fund made two new investments. ~
HRS,BRIEF-Harris Corp Q4 non-GAAP earnings per share $1.45 from continuing operations * Sees FY 2017 gaap earnings per share $5.53 to $5.73 from continuing operations ~
HUM,BRIEF-Aetna and Humana agree to sell certain assets to Molina Healthcare * Transactions contingent on successful closing of Aetna-Humana transaction ~
IP,BRIEF-International paper files for potential notes offering * Files for potential notes offering; size not disclosed - SEC filing  Source text for Eikon:  Further company coverage: ~
JPM,CORRECTED-MOVES-JP Morgan taps Gammage to run financial sponsor group NEW YORK, Aug 1 (IFR) - JP Morgan named John Gammage as global head of its financial-sponsor group, according to a memo obtained by IFR. He replaces Karen Simon who was named head of director advisory services earlier this year. ~
LMT,U.S. Air Force says first squadron of Lockheed F-35s combat-ready WASHINGTON, Aug 2 The U.S. Air Force on Tuesday declared an initial squadron of Lockheed Martin Corp  F-35A fighter jets ready for combat, said General Herbert Carlisle, commander of Air Combat Command. ~
MPC,BRIEF-Energy Transfer, Sunoco Logistics sell minority stake in Bakken Pipeline * Energy Transfer and Sunoco Logistics announce sale of minority stake in Bakken Pipeline Project to Enbridge and Marathon Petroleum ~
MRK,Wall St. falls as weak auto sales spur growth jitters NEW YORK Wall Street stocks fell on Tuesday, with each of the major indexes notching their worst day in about a month as economic data and weaker-than-expected auto sales spurred concerns about growth. ~US STOCKS-Wall St falls as weak auto sales spur growth jitters * Indexes down: Dow 0.49 pct, S&P; 0.64 pct, Nasdaq 0.9 pct   (Updates to market close) ~Deals of the day- Mergers and acquisitions Aug 2 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Tuesday: ~REFILE-Biogen draws takeover interest from Merck, Allergan - WSJ Aug 2 Biotechnology giant Biogen Inc  has drawn takeover interest from drug companies including Merck & Co Inc and Allergan Plc, the Wall Street Journal reported, citing people familiar with the matter. ~BRIEF-Biogen has drawn takeover interest from drug companies including Merck & Co and Allergan - WSJ * Biogen has drawn takeover interest from drug companies including Merck & Co and Allergan Plc- WSJ, citing sources  Source (http://on.wsj.com/2b0s6q9)   (Bengaluru Newsroom: +1-646-223-8780) ~
TAP,BRIEF-Molson Coors reports Q2 adj earnings per diluted share $1.11 * Quarterly underlying after-tax income $1.11 per diluted share ~Molson Coors reports better-than-expected quarterly sales Molson Coors Brewing Co  reported better-than-expected quarterly sales, helped by strong demand for its flagship Coors Light brew. ~UPDATE 1-Molson Coors reports better-than-expected quarterly sales Aug 2 Molson Coors Brewing Co reported better-than-expected quarterly sales, helped by strong demand for its flagship Coors Light brew. ~MillerCoors' net sales fall 3.5 pct Aug 2 MillerCoors LLC, the U.S. joint venture between brewers Molson Coors Brewing Co and SABMiller Plc, reported a 3.5 percent drop in net sales, hurt by lower demand for its cheaper brands such as Milwaukee's Best, Keystone and Miller High Life. ~
PFE,UPDATE 5-Pfizer beats estimates, but branded drugs disappoint Aug 2 Pfizer Inc reported better-than-expected quarterly results, driven by lower taxes and sales of generic medicines, but revenue from its branded patent-protected medicines brought disappointment. ~Pfizer in $486 million settlement of Celebrex, Bextra litigation NEW YORK Pfizer Inc  on Tuesday said it has reached a $486 million settlement of litigation accusing it of causing big losses for shareholders by concealing safety risks associated with its Celebrex and Bextra pain-relieving drugs. | Video  ~Pfizer in $486 mln settlement of Celebrex, Bextra litigation NEW YORK, Aug 2 Pfizer Inc on Tuesday said it has reached a $486 million settlement of litigation accusing it of causing big losses for shareholders by concealing safety risks associated with its Celebrex and Bextra pain-relieving drugs. ~UPDATE 2-Pfizer in $486 mln settlement of Celebrex, Bextra litigation NEW YORK, Aug 2 Pfizer Inc on Tuesday said it has reached a $486 million settlement of litigation accusing it of causing big losses for shareholders by concealing safety risks associated with its Celebrex and Bextra pain-relieving drugs. ~US STOCKS-Wall St opens lower; Pfizer weighs on Dow * Indexes down: Dow 0.2 pct, S&P; 0.23 pct, Nasdaq 0.33 pct   (Updates to open) ~Pfizer reaches $486 mln settlement of Celebrex, Bextra litigation Aug 2 Pfizer Inc on Tuesday said it has reached a $486 million settlement of nationwide litigation relating to its Celebrex and Bextra pain-relieving drugs. ~Pfizer revenue rises 11 percent Aug 2 Pfizer Inc's quarterly revenue rose about 11 percent, driven by sales of newer drugs and the acquisition of hospital products company Hospira last year. ~
PG,P&G; quarterly sales beat estimates Aug 2 Procter & Gamble Co, the maker of Tide detergent and Gillette shaving products, reported better-than-expected quarterly sales, helped by strong demand for its baby, feminine and home care products. ~
RCL,BRIEF-Royal Caribbean Cruises Q2 adjusted earnings $1.09/shr * Updated full year adjusted eps guidance to a range of $6.00 to $6.10. ~
HSY,Hershey, Alphabet spell another big day of bonds NEW YORK, Aug 2 (IFR) - Chocolate-maker Hershey and Google's parent company Alphabet spearheaded another deluge of deals in the US high-grade bond market Tuesday as companies seize the day to raise fresh cash. ~BRIEF-Hershey announces offering of notes due 2026 and notes due 2046 * The Hershey Company announces offering of notes due 2026 and notes due 2046 ~
MOS,UPDATE 4-Mosaic CEO sees opportunities to buy miners' fertilizer assets Aug 2 Miners that produce a diverse commodity mix may be willing to part with fertilizer assets, creating buying opportunities for producers of potash and phosphate, Mosaic Co Chief Executive Joc O'Rourke said on Tuesday. ~BRIEF-Mosaic CEO says no plans for dividend cut currently * Mosaic Co CEO, speaking to analysts, says he sees room for consolidation in potash, phosphate markets. ~BRIEF-Mosaic Company reports Q2 loss per share $0.03 * Q2 earnings per share view $0.12 -- Thomson Reuters I/B/E/S ~Mosaic reports loss as weak fertilizer prices, charges hurt Aug 2 U.S. fertilizer company Mosaic Co  reported a quarterly loss due to weak fertilizer prices and charges related to cost cuts. ~
VIAB.O,UPDATE 1-Viacom and Redstone's National Amusements held settlement talks -WSJ Aug 2 Top Viacom Inc executives recently held discussions with National Amusements Inc to settle litigation related to control of Sumner Redstone's media empire, the Wall Street Journal reported on Tuesday. ~Viacom and Redstone's National Amusements held settlement talks-WSJ Aug 2 Top Viacom Inc executives recently held discussions with National Amusements Inc to settle litigation surrounding the media empire of Sumner Redstone, the Wall Street Journal reported on Tuesday. ~BRIEF-Viacom held settlement talks with Sumner Redstone's National Amusements, but talks fell apart- CNBC, citing DJ * Viacom held settlement talks with Sumner Redstone's National Amusements, but talks fell apart- CNBC, citing DJ   Further company coverage:    (Bengaluru Newsroom: +1 646 223 8780) ~
HCN,BRIEF-Welltower adjusted FFO per share $1.15 * Fy2016 FFO per share view $4.56 -- Thomson Reuters I/B/E/S  Source text for Eikon:  Further company coverage:    (Bengaluru Newsroom : +1-646-223-8780) ~
